Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chinese PLA General Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Male or female participants aged ≥ 18 years-old
2. Primary diagnosis of migraine according to ICHD-3
3. Migraine attacks present for more than 1 year
4. Rimegepant is prescribed for the acute treatment of migraine by physician
5. Written informed consent must be obtained before participant is enrolled
You may not be if
Participants meeting any of the following criteria will not be included in the study:
1. Severe impairment of speech, vision, memory or cognition, or other factors that affect communication and ability to complete questionnaires and follow-up
2. Lack of necessary digital tools to complete questionnaires on a digital platform
3. History of hypersensitivity reaction to Rimegepant or to any of its components
4. Participants with severe hepatic impairment or end-stage renal disease
5. Any situation that the investigator believes may affect the patient's participation in the study
